4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0000899243-15-010076
Director sold 30,770 shares at an average $14.20 ($436,853)
- Director acquired 30,770 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZASLOFF MICHAEL A Director | 2015-12-16 | Option exercise | +16,538 | $11.68 | $193,164 | 42,863 | D |
| ZASLOFF MICHAEL A Director | 2015-12-16 | Sale | −16,538 | $14.19 | $234,740 | 26,325 | D |
| ZASLOFF MICHAEL A Director | 2015-12-17 | Option exercise | +14,232 | $11.68 | $166,230 | 40,557 | D |
| ZASLOFF MICHAEL A Director | 2015-12-17 | Sale | −14,232 | $14.20 | $202,113 | 26,325 | D |
| Derivatives | |||||||
| ZASLOFF MICHAEL A Director | 2015-12-16 | Option exercise · Stock Option (right to buy) | −16,538 | 14,232 | D | ||
| ZASLOFF MICHAEL A Director | 2015-12-17 | Option exercise · Stock Option (right to buy) | −14,232 | 0 | D | ||
| Open-market sales · 30,770 sh · avg $14.20 · $436,853 | |||||||
Loading xslF345X03/doc4.xml…